Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like 3 Biotech Stocks That Look Like Apple Did in the 1980s June 21, 2017 Study Reveals Huge Potential for mRNA Drug Targets March 18, 2018 Pfizer Wins Expanded FDA Nod for Cancer Drug Sutent November 16, 2017
